Entex Pac
NDC Package 66992-285-34

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Entex Pac is a . Marketed by Wraser Pharmaceuticals, Llc, this product is identified by NDC 66992-285 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
66992-285-34
Package Description
1 KIT in 1 PACKAGE, COMBINATION * 30 TABLET in 1 BOTTLE (66992-281-30) * 118 mL in 1 BOTTLE (66992-290-04)
Product Code
66992-285
11-Digit Billing Format
66992028534
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.

Clinical Specifications

Proprietary Name
Entex Pac
Dosage Form
-

Regulatory & Marketing

Labeler Name
Wraser Pharmaceuticals, Llc
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
08-30-2011
End Marketing Date
08-31-2013
Listing Expiration
08-31-2013
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66992-285-34 identifies a specific commercial package of 1 kit in 1 package, combination * 30 tablet in 1 bottle (66992-281-30) * 118 ml in 1 bottle (66992-290-04) of Entex Pac, labeled by Wraser Pharmaceuticals, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Wraser Pharmaceuticals, Llc on August 30, 2011. The current certification is valid through August 31, 2013.

How is this Wraser Pharmaceuticals, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66992028534. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66992-285-34
11-Digit CMS (5-4-2)
66992-0285-34

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.